223 related articles for article (PubMed ID: 33930029)
1. Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
Elens I; Deprez S; Billiet T; Sleurs C; Labarque V; Uyttebroeck A; Van Gool S; Lemiere J; D'Hooge R
PLoS One; 2021; 16(4):e0250228. PubMed ID: 33930029
[TBL] [Abstract][Full Text] [Related]
2. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z
Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
[TBL] [Abstract][Full Text] [Related]
4. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
Eissa DS; Ahmed TM
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
[TBL] [Abstract][Full Text] [Related]
5. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
[TBL] [Abstract][Full Text] [Related]
6. Maternal Haplotypes in
Tisato V; Muggeo P; Lupiano T; Longo G; Serino ML; Grassi M; Arcamone E; Secchiero P; Zauli G; Santoro N; Gemmati D
Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31443485
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
Zahra FT; Nahid NA; Islam MR; Al-Mamun MMA; Apu MNH; Nahar Z; Kabir AL; Biswas SK; Ahmed MU; Islam MS; Hasnat A
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153
[TBL] [Abstract][Full Text] [Related]
8. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.
Kim NK; Chong SY; Jang MJ; Hong SH; Kim HS; Cho EK; Lee JA; Ahn MJ; Kim CS; Oh D
Anticancer Res; 2006; 26(4B):2879-81. PubMed ID: 16886608
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Garcia-Orad A
Pharmacogenomics J; 2013 Dec; 13(6):498-506. PubMed ID: 23089671
[TBL] [Abstract][Full Text] [Related]
10. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy].
Liao QC; Li XL; Liu ST; Zhang Y; Li TY; Qiu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027
[TBL] [Abstract][Full Text] [Related]
11. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.
Chae H; Kim M; Choi SH; Kim SK; Lee JW; Chung NG; Cho B; Kim Y
J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230
[TBL] [Abstract][Full Text] [Related]
12. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
[TBL] [Abstract][Full Text] [Related]
13. Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.
He HR; Chen SY; You HS; Hu SS; Sun JY; Dong YL; Lu J
Pharmacogenomics J; 2014 Oct; 14(5):432-8. PubMed ID: 24637499
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
[TBL] [Abstract][Full Text] [Related]
15. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.
Mosaad YM; Abousamra NK; Elashery R; Fawzy IM; Eldein OA; Sherief DM; El Azab HM
Leuk Lymphoma; 2015; 56(9):2699-705. PubMed ID: 25629981
[TBL] [Abstract][Full Text] [Related]
17. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
[TBL] [Abstract][Full Text] [Related]
18. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
[TBL] [Abstract][Full Text] [Related]
19. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.
Costea I; Moghrabi A; Laverdiere C; Graziani A; Krajinovic M
Haematologica; 2006 Aug; 91(8):1113-6. PubMed ID: 16870553
[TBL] [Abstract][Full Text] [Related]
20. Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury.
Krawczuk-Rybak M; Grabowska A; Protas PT; Muszynska-Roslan K; Holownia A; Braszko J
Adv Med Sci; 2012; 57(2):266-72. PubMed ID: 23154429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
